Technology
Health
Biotechnology

Fennec Pharmaceuticals

$5.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell FENC and other stocks, options, ETFs, and crypto commission-free!

About

Fennec Pharmaceuticals Inc. Common Stock, also called Fennec Pharmaceuticals, is a biopharmaceutical company, which engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. Read More The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Employees
3
Headquarters
Durham, North Carolina
Founded
1996
Market Cap
104.45M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
82.48K
High Today
$5.29
Low Today
$5.10
Open Price
$5.25
Volume
21.66K
52 Week High
$14.99
52 Week Low
$5.10

Collections

Technology
Health
Biotechnology
US
North America

News

MarketBeatFeb 14

Stock Price, News, & Analysis for Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was founded in 1996 and is...

21

Earnings

-$0.15
-$0.13
-$0.11
-$0.09
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.14 per share
Actual
-$0.15 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.